- Home
- PMM vs RVNC Comparison
PMM vs RVNC Comparison
Compare PMM & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMM
- RVNC
- Stock Information
- Founded
- PMM 1989
- RVNC 1999
- Country
- PMM United States
- RVNC United States
- Employees
- PMM N/A
- RVNC N/A
- Industry
- PMM Investment Managers
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- PMM Finance
- RVNC Health Care
- Exchange
- PMM Nasdaq
- RVNC Nasdaq
- Market Cap
- PMM 287.2M
- RVNC 320.5M
- IPO Year
- PMM N/A
- RVNC 2014
- Fundamental
- Price
- PMM $6.05
- RVNC $3.09
- Analyst Decision
- PMM
- RVNC Hold
- Analyst Count
- PMM 0
- RVNC 9
- Target Price
- PMM N/A
- RVNC $8.45
- AVG Volume (30 Days)
- PMM 118.3K
- RVNC 3.6M
- Earning Date
- PMM 01-01-0001
- RVNC 11-07-2024
- Dividend Yield
- PMM 4.68%
- RVNC N/A
- EPS Growth
- PMM N/A
- RVNC N/A
- EPS
- PMM 0.23
- RVNC N/A
- Revenue
- PMM N/A
- RVNC $256,945,000.00
- Revenue This Year
- PMM N/A
- RVNC $11.28
- Revenue Next Year
- PMM N/A
- RVNC $27.21
- P/E Ratio
- PMM $26.52
- RVNC N/A
- Revenue Growth
- PMM N/A
- RVNC 25.82
- 52 Week Low
- PMM $5.00
- RVNC $2.30
- 52 Week High
- PMM $6.42
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- PMM 34.89
- RVNC 33.47
- Support Level
- PMM $6.04
- RVNC $3.06
- Resistance Level
- PMM $6.43
- RVNC $3.09
- Average True Range (ATR)
- PMM 0.08
- RVNC 0.11
- MACD
- PMM -0.03
- RVNC 0.02
- Stochastic Oscillator
- PMM 16.10
- RVNC 6.90
About PMM Putnam Managed Municipal Income Trust
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.